Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Disseminated Intravascular Coagulation

3,4-methylenedioxyamphetamine has been researched along with Disseminated Intravascular Coagulation in 3 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrett, PJ1
Taylor, GT1
Fineschi, V1
Centini, F1
Mazzeo, E1
Turillazzi, E1
Chadwick, IS1
Curry, PD1
Linsley, A1
Freemont, AJ1
Doran, B1

Other Studies

3 other studies available for 3,4-methylenedioxyamphetamine and Disseminated Intravascular Coagulation

ArticleYear
'Ecstasy' ingestion: a case report of severe complications.
    Journal of the Royal Society of Medicine, 1993, Volume: 86, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Amphetamine; Designer Drugs; Disseminated

1993
Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases.
    Forensic science international, 1999, Sep-30, Volume: 104, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Disseminated Intravascular Coagulation; Fatal Outcome; Forensi

1999
Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.
    Journal of the Royal Society of Medicine, 1991, Volume: 84, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Designer Drugs; Disseminated Intravascular Coagulation; F

1991